- Previous Close
4.82 - Open
4.66 - Bid 5.12 x 300
- Ask 5.20 x 300
- Day's Range
4.42 - 5.20 - 52 Week Range
1.86 - 9.33 - Volume
2,421,906 - Avg. Volume
1,922,966 - Market Cap (intraday)
371.871M - Beta (5Y Monthly) 3.69
- PE Ratio (TTM)
-- - EPS (TTM)
-0.59 - Earnings Date Mar 31, 2025
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
8.50
ASP Isotopes Inc., a development stage advanced materials company, focuses on the production, distribution, marketing, and sale of isotopes. It engages in the production and commercialization of Molybdenum-100, a non-radioactive isotope for the medical industry; Carbon-14; and Silicon-28. The company is also developing Quantum Enrichment technology to produce Ytterbium-176, Nickel-64, Lithium 6, Lithium7, and Uranium-235. ASP Isotopes Inc. was incorporated in 2021 and is headquartered in Washington, District Of Columbia.
aspisotopes.comRecent News: ASPI
View More
Performance Overview: ASPI
Trailing total returns as of 4/2/2025, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC) .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: ASPI
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: ASPI
View MoreValuation Measures
Market Cap
347.37M
Enterprise Value
331.72M
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
70.43
Price/Book (mrq)
8.98
Enterprise Value/Revenue
98.04
Enterprise Value/EBITDA
--
Financial Highlights
Profitability and Income Statement
Profit Margin
0.00%
Return on Assets (ttm)
-27.03%
Return on Equity (ttm)
-92.64%
Revenue (ttm)
4.14M
Net Income Avi to Common (ttm)
-35.11M
Diluted EPS (ttm)
-0.59
Balance Sheet and Cash Flow
Total Cash (mrq)
61.89M
Total Debt/Equity (mrq)
73.77%
Levered Free Cash Flow (ttm)
-17.81M